A clinical feasible stem cell encapsulation ensures an improved wound healing

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Stem Cell Biology

Background:

• Stem cell therapy holds promise but faces challenges in cell yield, formulation, and post-cryopreservation viability.
• Current methods struggle to protect encapsulated stem cells during clinical procedures like cryopreservation and injection.

Purpose of the Study:

• To develop and evaluate a novel biosynsphere technology for encapsulating stem cells.
• To ensure the viability, functionality, and clinical applicability of encapsulated adipose-derived stromal cells (ADSCs).

Main Methods:

• Development of biosynspheres using clinically-ready biomaterials with controlled microsphere size.
• Assessment of ADSC viability and functionality post-encapsulation and after various handling procedures (cryopreservation, centrifugation, injection).
• Evaluation of biosynsphere efficacy in a swine full skin defect model for tissue regeneration.

Main Results:

• Biosynspheres successfully encapsulated ADSCs, maintaining their viability and function.
• Encapsulated ADSCs demonstrated enhanced protection against cryopreservation, thawing, centrifugation, and injection stresses.
• In vivo studies showed biosynspheres promoted accelerated wound healing, reduced scarring, and normalized collagen deposition.

Conclusions:

• Biosynsphere technology offers a promising solution to current limitations in stem cell encapsulation for therapy.
• This biofabrication method enhances stem cell survival and function, facilitating tissue regeneration.
• Biosynspheres represent a significant advancement for clinical applications in regenerative medicine.